Trends in participant race and sex reporting in lung cancer phase III clinical trials

BACKGROUND: Clinical trials are an essential part of advancing care for cancer patients. Historically, however, racial minorities and females have been underrepresented in these trials. Efforts like the National Institute of Health Revitalization Act attempted to mitigate these disparities, but desp...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Faaiq N., Manochakian, Rami, Lou, Yanyan, Colon‐Otero, Gerardo, Sher, Taimur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
The publication of this supplement has been funded by Gilead Sciences, Inc.
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440837/
https://www.ncbi.nlm.nih.gov/pubmed/37421166
http://dx.doi.org/10.1002/cnr2.1856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440837/
https://www.ncbi.nlm.nih.gov/pubmed/37421166
http://dx.doi.org/10.1002/cnr2.1856

Ejemplares similares